We confirmed that BCR-ABL1-activated GAB2 was crucial to survival of CML cells and that knockdown of GAB2 led to apoptosis in the TKI-sensitive CML cell line JURL-MK2 (Figure 3C). Here, GAB2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.